Kelley4NH, a social media user known for sharing commentary on public health and media issues, posted several statements between May 31 and June 1, 2026. The posts focus on the pharmaceutical industry, its relationship with the media, and its alleged ties to government entities.
On May 31, Kelley4NH wrote: “Create the problem. Sell the solution. Or, is this case… Create the diseases. Sell the fake “cure” to scared people through your snake oil poison injections.”
Continuing this line of criticism on June 1, Kelley4NH stated: “More keeping the truth from the people because big p-HARM-a controls the media. This is why drug advertising MUST be banned on television like other countries. The $$$ buys the narrative.” In this post, Kelley4NH calls for a ban on drug advertising on television in the United States and alleges that financial interests shape public narratives.
Later that same day, Kelley4NH added: “And, this demon is interlocked with the intelligence arm (and more) of the US government.”
The concerns about pharmaceutical advertising reflect ongoing debates in U.S. policy circles regarding direct-to-consumer drug marketing. The United States is one of only two countries where such advertising is permitted; many nations prohibit it due to concerns over patient safety and misinformation (source). Critics argue that extensive pharmaceutical promotion can influence prescribing patterns and healthcare costs.
Questions regarding connections between private industries and government agencies have also been raised in various contexts over recent years (source). These discussions often center around transparency and regulatory oversight.
